Does renal denervation provide safe and sustained blood pressure reductions and preserve kidney function in hypertensive patients?
Hypertensive patients
Renal denervation (RDN)
Office and ambulatory blood pressure reductions, kidney function, and safety at 3 yearssurrogate
Real-world data from the Global SYMPLICITY Registry indicates that renal denervation provides safe and sustained reductions in blood pressure up to 3 years in hypertensive patients.
Long-term data from the Global SYMPLICITY Registry representing the largest available cohort of hypertensive patients receiving RDN in a real-world clinical setting demonstrate both the safety and efficacy of the procedure with significant and sustained office and ambulatory BP reductions out to 3 years.
Building similarity graph...
Analyzing shared references across papers
Loading...
Felix Mahfoud
Interventional Cardiology
Michael Böhm
Heart Failure & Transplant
Roland E. Schmieder
Preventive Cardiology
European Heart Journal
University College London
The University of Western Australia
Saarland University
Building similarity graph...
Analyzing shared references across papers
Loading...
Mahfoud et al. (Wed,) studied this question.
synapsesocial.com/papers/69d56f8d75589c71d767d9ab — DOI: https://doi.org/10.1093/eurheartj/ehz118
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: